We regularly represent buyers, target companies, controlling shareholders, management, lenders and institutional investors in large transactions among listed and unlisted Chinese companies. Some of our clients are state-owned companies dealing with highly complex issues.
Through established relationships with the China Securities Regulatory Commission (CSRC), Ministry of Commerce (MOC), China Banking Regulatory Commission (CBRC), China Insurance Regulatory Commission (CIRC) and other regulatory bodies, we provide informed advice on client matters. We advise on take-private transactions and tender offers on Chinese exchanges, leveraged buyouts and negotiated acquisitions and divestitures.
We are also experienced in distressed M&A, spin-offs and business sales. Several of our partners have extensive experience in leveraged buyouts and other M&A transactions in the US, Europe and other jurisdictions.
Our M&A offerings mainly include:
● Mergers and acquisitions of listed and unlisted companies, including on a leveraged basis
● Strategic investments in listed and unlisted companies
● Asset and equity acquisition in listed and unlisted companies
● Divestment and spin-offs involving listed and unlisted companies